Scholarlink

The prevalence of the metabolic syndrome (METS) increases as women transit the menopause. Diagnostic features include obesity, hypertension, dyslipidemia, and hyperglycemia, many which are related to insulin resistance, lifestyle and excessive weight. Throughout time, definitions of the syndrome have changed, fruit of the consensus of various scientific organizations, but overall, it has helped improve the knowledge of its biology. The syndrome is accompanied by alterations of cytokines, digestive hormones, and anti-oxidative capacity. Associated comorbidities and risks mainly include insulin resistance and type 2 diabetes mellitus, cardiovascular disease, and other conditions such as sexual dysfunction, sleep disorders, gynecological pathology, urinary complaints, and osteoporosis.

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The Metabolic Syndrome During Female Midlife and Beyond

  • 章节

  • 发表日期：

    2025年

查看全文
  • Peter Chedraui,
  • Faustino R. Pérez-López

摘要

The prevalence of the metabolic syndrome (METS) increases as women transit the menopause. Diagnostic features include obesity, hypertension, dyslipidemia, and hyperglycemia, many which are related to insulin resistance, lifestyle and excessive weight. Throughout time, definitions of the syndrome have changed, fruit of the consensus of various scientific organizations, but overall, it has helped improve the knowledge of its biology. The syndrome is accompanied by alterations of cytokines, digestive hormones, and anti-oxidative capacity. Associated comorbidities and risks mainly include insulin resistance and type 2 diabetes mellitus, cardiovascular disease, and other conditions such as sexual dysfunction, sleep disorders, gynecological pathology, urinary complaints, and osteoporosis.